Citrate synthase: an immunochemical investigation of interspecies diversity  by Pullen, Ann M. et al.
Volume 182, number 1 FEBS 2332 March 1985 
Citrate synthase: an immunoc~emical investigation of 
int~rsp~cies diversity 
Ann M. Pullen, Nigel Budgen, Michael J. Danson* and David W. Hough 
Department of Biochemistry, University of Bath, Bath BA2 1A Y, England 
Received 18 January 1985 
Rabbit antibodies have been raised to pig heart citrate synthase. Using purified IgG, competitive enzyme- 
linked immunoassays and assays of citrate synthase activity indicate the presence of antibodies to a number 
of antigenic sites on the enzyme, only some of which are essential for catalytic activity. From a comparison 
of citrate synthases from prokaryotic and eukaryotic organisms, the degree of interaction between antibody 
and enzyme was in the order: pig heart > pigeon breast > bacillus megaterium > Escher~ch~u cali. These 
findings are discussed in terms of the known interspecies diversity of the enzyme. 
Citrate synthase Immunochemistry Enzyme diversity 
1. INTRODUCT~GN 
Citrate synthase possesses a diversity of subunit 
structure, catalytic activity and allosteric regula- 
tion that shows a strong correlation with the tax- 
onomic status of the source organism [1,2]. The 
‘large’, hexameric [3,4] citrate synthases, found 
exclusively in Gram-negative bacteria IS], are 
allosterically inhibited by NADH and, in the 
facultative anaerobes of this group, the enzyme is 
subject to additional inhibition by 2-oxoglutarate 
[6,7]. In contrast, Gram-positive bacteria and 
eukaryotes possess ‘small’ dimeric citrate syn- 
thases [S-lo] which are isosterically inhibited by 
ATP but are insensitive to NADH and 2-oxogluta- 
rate [1,2,11]. 
To begin an examination of this diversity of 
citrate synthases at the fine structural level, we 
have compared the enzyme from a wide range of 
sources using immunochemical methods. An- 
tibodies have been raised to pig heart citrate syn- 
thase and the cross-reactivities between the en- 
zymes from the bacterial and eukaryotic organisms 
examined using both competitive enzyme-linked 
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immnnoassays and assays of citrate synthase ac- 
tivity. 
2. EXPERIMENTAL 
All chemicals used were of analytical grade. Pig 
heart citrate synthase was from Boehringer (Mann- 
heim, FRG) and pigeon breast muscle citrate syn- 
thase was from Sigma (Poole, England). Citrate 
synthases from E. coli and B. megaterium were 
purified as described previously [4,8]. All 4 en- 
zymes ran as single protein bands on SDS gel elec- 
trophoresis. Enzyme activity was assayed spec- 
trophotometrically at 412 nm [12]. 
Rabbits were immunized with pig heart citrate 
synthase and IgC was purified from the serum by 
precipitation with ammonium sulphate (45% 
saturated) followed by ion-exchange chromato- 
graphy using DEAE-ceIlulose. This IgG was used 
in a11 experiments and is referred to as IgG-anti- 
PHCS. 
IgG-anti-PHCS was assayed by an ELISA 
method 1131. EIA cuvettes were coated for 3 h at 
37OC with pig heart citrate synthase (1 /g/ml of 0.1 
M carbonate buffer, pH 9.6). After washing with 
0.15 M NaCl containing 0.05% Tween 20 (saIine/ 
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Tween), antibody samples at suitable dilutions in 
saline/Tween were added and incubated for 2 h at 
37°C. After further washing, the cuvettes were 
treated with alkaline phosphatase-goat nti-rabbit 
IgG for 18 h at 4°C. Finally, the cuvettes were 
washed and incubated with substrate solution (p- 
nitrophenyl phosphate, 1 mg/ml of 0.05 M car- 
bonate buffer, pH 9.8). The reaction was stopped 
with 1 .O M NaOH and the absorbance measured at 
405 nm. 
A competitive assay, based on the ELBA 
method, was used in cross-reactivity studies: IgG- 
anti-PHCS was incubated for 1 h at 37°C with the 
appropriate antigen in solution and then transfer- 
red to an antigen-coated cuvette. Other details for 
the competitive assay were as described above. 0 1 -8 0 10 16' ’ 10 -6 b-5 7-4 10 10 
To detect interaction of antibody with enzyme in 
free solution, purified citrate synthase was in- 
cubated with IgG-anti-PHCS for 5 min, and then 
sufficient immobilized protein A in the form of in- 
tact Staphylococcus aureus cells was added to bind 
all the IgG. The mixture was incubated for 10 min 
at 25°C and centrifuged to sediment the cells. 
Samples of supernatant were assayed for citrate 
synthase activity as described above. 
competing antigen added (g) 
Fig. 1. Inhibition of antibody binding to solid-phase an- 
tigen in the competitive ELISA system by addition of 
purified pig heart citrate synthase. Antiserum at stan- 
dard dilution (l/1000) was incubated for 1 h at 37°C 
with varying amounts of pig heart citrate synthase (o), 
albumin (A), or myoglobin (m), and then transferred to 
a cuvette coated with pig heart citrate synthase. Binding 
of antibody to the solid-phase antigen was assayed using 
alkaline phosphatase-goat nti-rabbit IgG, as described 
3. RESULTS in section 2. 
3.1. Characterization of antibodies to pig heart 
citrate synthase 3.3. Effects of antibody on citrate synthase 
The ELISA method was used to detect an- 
tibodies to pig heart citrate synthase in rabbit 
serum and to confirm retention of antibody activi- 
ty during purification of IgG-anti-PHCS. The 
competitive ELISA detected l-100 pg pure en- 
zyme/ml whereas imilar concentrations of albumin 
and myoglobin did not inhibit binding of antibody 
to solid-phase antigen (fig. 1). 
activity 
3.2. Species cross-reactivity by competitive ELISA 
Competitive ELISA with pigeon citrate synthase 
as solid phase antigen was used to compare the ef- 
fects of different competing purified citrate syn- 
thase antigens in the fluid phase (fig.2). Competi- 
tion with solid phase antigen for binding to IgG- 
anti-PHCS was seen with citrate synthases in the 
order pig> pigeon> B. megaterium. The E. coli 
enzyme showed no significant interaction in this 
assay. 
IgG-anti-PHCS was found to inhibit citrate syn- 
thase enzymic activity, again in the order pig> 
pigeon, B. megaterium (fig.3). Normal rabbit IgG 
produced no inhibition. A small stimulation of the 
activity of the E. coli enzyme was observed, but its 
response to the allosteric effecters, NADH and 
2-oxoglutarate, remained unaffected. IgG-anti- 
PHCS also inhibited citrate synthase in crude ex- 
tracts of pig heart, liver, kidney and brain. 
To detect binding of antibody to non-essential 
sites on the enzyme, citrate synthase-antibody im- 
mune complexes were removed with Protein A (see 
section 2). The amount of antibody required to 
produce a given level of inhibition of pig heart 
citrate synthase was reduced by this Protein A 
treatment (fig.4), suggesting that IgG-anti-PHCS 
contains antibodies to a number of antigenic sites 
on the citrate synthase molecule, only some of 
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Fig.2. Inhibition of antibody binding to solid-phase an- 
tigen in the competitive ELISA by citrate synthases from 
various species. The antibody was incubated with vary- 
ing amounts of citrate synthase from pig heart (o), 
pigeon breast (m), B. megaterium (D), or E. coli (A) 
prior to transfer to cuvettes coated with pigeon breast 
citrate synthase. Binding of antibody to the solid-phase 
antigen was assayed using alkaline phosphatase-goat 
anti-rabbit IgG, as described in section 2. 
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Fig.3. Effect of IgG-anti-PHCS on the enzymic activity 
of citrate synthase. Purified citrate synthase from pig 
heart (o), pigeon breast (m), B. megaterium (D), or E. 
co/i (A) was incubated with varying amounts of IgG- 
anti-PHCS and then assayed for residual citrate synthase 
activity as described in section 2. 
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Fig.4. Inhibition of citrate synthase activity by IgG-anti- 
PHCS in the presence and absence of S. aureus protein 
A. Purified citrate synthase from pig heart or E. coli was 
incubated with varying amounts of IgG-anti-PHCS. 
Residual citrate synthase activity was then assayed as 
described in section 2 before and after removal of 
antibody-enzyme complexes using protein A. Pig heart 
citrate synthase before (e) and after (0) protein A: E. 
coli citrate synthase before (A) and after (A) protein A. 
which are essential for enzymic activity. Similarly, 
binding of antibody to E. co/i citrate synthase was 
detected by the use of Protein A (fig.4) even 
though no inhibition of activity was observed 
(fig.3). 
4. DISCUSSION 
This paper represents the first report of an im- 
munochemical comparison of citrate synthases 
from a wide range of organisms, and its signifi- 
cance stems from the established patterns of struc- 
tural and regulatory diversity displayed by this en- 
zyme [1,2]. 
With IgG purified from a rabbit polyclonal an- 
tiserum to pig heart citrate synthase, we have 
detected antibody activity against he enzyme using 
direct and competitive ELISA methods and through 
enzymic assays in the presence and absence of Pro- 
tein A. These same methods were then used to 
compare citrate synthases from prokaryotic and 
eukaryotic organisms and the degree of interaction 
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between antibody and enzyme was found to be in 
the order: pig heart > pigeon breast > B. megater- 
ium > E. coli. 
The data establish several important points. The 
different types of citrate synthase do share struc- 
tural similarities in that they appear to possess a 
number of common antigenic determinants. Align- 
ment of the sequences of the E. co& and pig heart 
enzymes [ 14,151 shows regions of homology 
throughout the sequence, including amino acids 
implicated in the catalytic mechanism of the pig 
heart citrate synthase. Surprisingly, however, an- 
tibodies inhibiting enzymic activity of the pig en- 
zyme did not inhibit that from E. coli. Virtually no 
structural data are available for citrate synthases 
from Gram-positive bacteria. The interaction of 
IgG-anti-PHCS was more pronounced with Bacillus 
citrate synthase than with the E. co& enzyme, sug- 
gesting that the citrate synthases from the Gram- 
positive bacterium and the eukaryote may be struc- 
turally close, not only in oligomeric and regulatory 
features [1,2] but also perhaps in sequence and/or 
conformation. Such observations add to the ac- 
cumulating observed similarities between mito- 
chondrial and Gram-positive bacterial citric acid 
cycle enzymes [l], similarities which should be 
borne in mind when considering organelle 
evolution. 
Finally, it is felt that the results presented here 
using polyclonal antisera confirm the feasibility of 
investigating the structural diversity of citrate syn- 
thase using immunological methods. We have 
tested a number of different methods to detect 
antibody-enzyme interaction and the ability to do 
this in impure preparations will be essential to any 
immunochemical comparisons between enzymes 
from a large number of different organisms. With 
this basis, future work will involve a monoclonal 
antibody system which will enable us to define and 
identify on the different enzymes regions of com- 
mon sequence and conformation and to investigate 
their relationship with enzymic activity and regula- 
tion. 
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